Fulcrum Therapeutics (FULC) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.61
-0.53
-0.46
-0.38

Details

Expected EPS
-0.44
Actual EPS
-0.38
Surprise EPS
0.06
Surprise Percent
+13.64%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.38 per share for Q2 2023.

0 Comments

Share your thoughts